| J9271 | Injection, pembrolizumab, 1 mg | 20,000 | $40 | $860K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 930 | $100 | $93.8K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 40,100 | $1 | $80.2K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 58,500 | $1 | $58.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 450 | $120 | $53.3K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 400 | $90 | $36.8K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 190 | $70 | $12.7K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 200 | $60 | $11.1K |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 630 | $10 | $8.8K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 80 | $100 | $7.2K |